SCHEMBL409191

SCHEMBL409191

[C-]#[N+]c1ccccc1[N+]#[C-]

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.31
ALOX12 P18054 1/20 0.31
HDAC8 Q9BY41 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30050643 1.00 CYP2A6 (0.31) CYP2A6ALOX12HDAC8HDAC6
SCHEMBL8531624 0.96
SCHEMBL29955606 0.83 HDAC8 (0.38) ALOX12HDAC8HDAC6
SCHEMBL29954595 0.78
SCHEMBL653876 0.78
SCHEMBL29951766 0.78
SCHEMBL29953266 0.78
SCHEMBL10254578 0.78
SCHEMBL7911284 0.78
SCHEMBL13167873 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674128-B2 Conductive organometallic framework THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-03-18 US claimed
US-20120017668-A1 CONDUCTIVE ORGANOMETALLIC FRAMEWORK THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-01-26 US claimed
EP-2382043-A1 CONDUCTIVE ORGANOMETALLIC FRAMEWORK The Regents of the University of California (US) 2011-11-02 EP claimed
WO-2010083418-A1 CONDUCTIVE ORGANOMETALLIC FRAMEWORK THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-07-22 WO claimed
EP-0261733-B1 CONDUCTIVE POLYMER COMPOSITIONS SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1992-01-15 EP claimed
US-5034463-A Forming a solution of an electroconductive polymer in a solvent, a metallized polymer SHELL OIL CORPORATION (US) 1991-07-23 US claimed
EP-0261733-A2 Conductive polymer compositions SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-03-30 EP claimed
US-4271033-A DIMERIC, DINUCLEAR COMPLEX CONTAINING FOUR BINUCLEATING DIISOCYANIDE BRIDGE LIGANDS, SECONDARY OXIDANT CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 1981-06-02 US claimed
US-4169030-A PRODUCTION OF HYDROGEN FUEL BY SOLAR PHOTOLYSIS OF WATER CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 1979-09-25 US claimed
JP-3261793-A None JP disclosed
US-12296325-B2 Catalyst for hydrosilylation reaction, hydrogenation reaction, and hydrosilane reduction reaction KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2025-05-13 US disclosed
EP-3195932-B1 HYDROSILYLATION REACTION CATALYST UNIV KYUSHU NAT UNIV CORP (JP) 2024-08-21 EP disclosed
US-11793071-B2 Organic compound, electroluminescent material, and use thereof WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-10-17 US disclosed
US-20230241594-A1 CATALYST FOR HYDROSILYLATION REACTION, HYDROGENATION REACTION, AND HYDROSILANE REDUCTION REACTION KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-08-03 US disclosed
EP-0261733-A2 Conductive polymer compositions SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-03-30 EP disclosed
US-4426486-A Clear aquagel polyimide film MOBIL OIL CORPORATION (US) 1984-01-17 US disclosed
US-4405550-A CLARITY, COAGULATION, APROTIC SOLVENTS, REPLACEMENTS, BIAXIAL MOBIL OIL CORPORATION (US) 1983-09-20 US disclosed
EP-0064813-A2 A method of making optically clear oriented polyimide film MOBIL OIL CORPORATION (US) 1982-11-17 EP disclosed
US-4271033-A DIMERIC, DINUCLEAR COMPLEX CONTAINING FOUR BINUCLEATING DIISOCYANIDE BRIDGE LIGANDS, SECONDARY OXIDANT CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 1981-06-02 US disclosed
US-4169030-A PRODUCTION OF HYDROGEN FUEL BY SOLAR PHOTOLYSIS OF WATER CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 1979-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11793071-B2 Organic compound, electroluminescent material, and use thereof LEF1, SLCO2A1, SLCO2B1 CYP2A6 3281/4885ALOX12 44/4885HDAC8 4868/4885
US-12296325-B2 Catalyst for hydrosilylation reaction, hydrogenation reaction, and hydrosilane reduction reaction H1-0, HVCN1, H1-2 CYP2A6 3349/4885ALOX12 288/4885HDAC8 2522/4885
US-20230241594-A1 CATALYST FOR HYDROSILYLATION REACTION, HYDROGENATION REACTION, AND HYDROSILANE REDUCTION REACTION H1-0, HVCN1, H1-2 CYP2A6 3349/4885ALOX12 288/4885HDAC8 2522/4885
US-20120017668-A1 CONDUCTIVE ORGANOMETALLIC FRAMEWORK IDH2, DBF4, HCN4 CYP2A6 3249/4885ALOX12 3628/4885HDAC8 3867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.